White House Declares Increased Focus on Women’s Health in US

The US Department of Health and Human Services (HHS) announced Monday the creation of an official Women’s Health Division within the National Institutes of Health (NIH), according to a release.¹

Signed in an executive order titled “Advancing Women’s Health to Improve Outcomes in All Phases of Life,” President Trump and First Lady Melania are notably championing the effort to “strengthen scientific research, accelerate medical breakthroughs, and improve health outcomes for American women and girls.”

“This announcement raises awareness about the fact that there are many diseases that disproportionately or differentially affect women and that women's health research has long been underfunded,” Natalie DiPietro Mager, PharmD, PhD, MPH, professor of pharmacy practice at Ohio Northern University and host of Drug Topics® Scripted for Her podcast, told us. “The previous administration also sought to shed more light on the importance of women's health, and this new division provides an opportunity to continue a focus in this area.”

The newly signed executive order directs federal agencies to establish the NIH Women’s Health Division within 90 days, while revoking previous executive actions to streamline national priorities.^1,2

READ MORE: Menopause Status, Symptoms Remain Inconsistently Documented

Beyond federal administrative structures, national policy leaders stress that the overarching objective is translating scientific discoveries into practical clinical care across every phase of a woman's life.

Practitioners emphasize that bridging this gap depends heavily on frontline providers, particularly community pharmacists who frequently serve as the primary health care touchpoint for American patients.^2,3

Expanding Research into Clinical Pharmacy Practice

The federal initiative targets conditions that uniquely or disproportionately affect women, ranging from cardiovascular disease and stroke to endometriosis, fibroids, polyendocrine metabolic ovary syndrome, and menopausal health. Alongside structural reorganization, federal health officials have highlighted recent progress, including the approval of new therapeutic options such as a generic Premarin formulation and non-hormonal options for menopausal vasomotor symptoms.^1,2,4

For community pharmacists, these scientific and regulatory developments directly expand clinical opportunities to improve patient care.^3,5

Pharmacists play an essential role in managing complex therapeutic regimens for conditions like uterine fibroids and polycystic ovarian syndrome, ensuring accurate medication dosages, identifying adverse interactions, and counseling patients on treatment adherence.

Addressing Gaps in Access and Representation

Beyond traditional dispensing, pharmacists are increasingly recognized for closing gaps in primary care and women's health services. Approximately 96% of the American population resides within 10 miles of a community pharmacy, allowing pharmacists to interact with patients far more frequently than traditional physician visits, according to a study in Pharmacy (Basel).³

This high level of accessibility positions pharmacy staff to address historical disparities in research and clinical awareness. Historically, women were underrepresented in clinical trials, and trial data frequently omitted analyses based on sex as a biological variable, according to Sarah Chew, MPH, programs manager with the Society for Women’s Health Research, who joined us earlier this year to discuss advocacy needed in women’s health research.

Because pharmacists are trusted figures embedded in local communities, they can help educate female patients about participating in clinical research and advocate for stage-specific preventive care. Pharmacists support maternal health through preconception counseling, chronic disease management for conditions like hypertension and diabetes, prenatal vitamin guidance, and over-the-counter remedies for pregnancy symptoms.^3,5

Navigating Implementation and Future Outlook

To guide federal coordination, the order creates the White House Women's Health Task Force, co-chaired by HHS Secretary Robert F. Kennedy Jr. and White House Chief of Staff Susie Wiles.^1,2,4

Although public health groups welcomed the elevated focus on female biology, research advocates note that the executive order does not allocate immediate new federal funds. Additionally, policy analysts point out that recent federal budget shifts and grant cancellations under administrative restructuring have created ongoing debates about long-term research backing, according to a USA Today report.⁴

Nevertheless, pharmacy advocates maintain that integrating community pharmacists into broader clinical strategies offers a practical and cost-effective approach to expanding preventive care, improving medication safety, and optimizing health outcomes throughout every stage of a woman’s life.³

“Ensuring that unbiased, evidence-based research is conducted and sufficient funding is secured will be key to the new division's success,” concluded Mager in her discussions with Drug Topics. “Moving forward, it would be even better if the division could be elevated to an institute within the NIH.”

READ MORE: Women’s Health Resource Center

REFERENCES

1. President Trump signs historic executive order to advance women’s health, championed by First Lady Melania Trump. US Department of Health and Human Services. October 19, 2026. Accessed October 22, 2026. https://www.hhs.gov/press-room/trump-flotus-womens-health-executive-order-new-nih-division.html

2. Advancing Women’s Health to Improve Outcomes in All Phases of Life. White House. October 19, 2026. Accessed October 22, 2026. https://www.whitehouse.gov/presidential-actions/2026/10/advancing-womens-health-to-improve-outcomes-in-all-phases-of-life/

3. DiPietro Mager N, Bright D, Shipman AJ. Beyond contraception: pharmacist roles to support maternal health. Pharmacy (Basel). 2022;10(6):163. 2022 Nov 30. doi:10.3390/pharmacy10060163

4. Walrath-Holdridge M. Trump’s women’s health order promises change. What’s next? USA Today. October 21, 2026. Accessed October 22, 2026. https://www.usatoday.com/story/news/politics/2026/10/21/trump-womens-health-executive-order-explained/92361168007/

5. Pharmacists and women's health: bridging the knowledge gap. North Atlanta Ob/Gyn. January 12, 2024. Accessed October 22, 2026. https://www.naobgyn.com/post/pharmacists-and-womens-health-bridging-the-knowledge-gap